The Effect of Gemcabene on Insulin Sensitivity in Nondiabetic Subjects

Clinical trial NCT02586168 · COMPLETED

Trial details

NCT number: NCT02586168
Sponsor: NeuroBo Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Insulin Sensitivity

Start date: 2001-07-01
Primary completion: 2001-10-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.